National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
November 1, 2011 • Volume 8 / Number 21


President Signs Executive Order on Reducing Drug Shortages

On October 31, President Barack Obama signed an executive order directing the Food and Drug Administration (FDA) to take action to help further reduce and prevent shortages of prescription drugs, including shortages of many cancer medicines. For more information, see an FDA report and White House fact sheet on drug shortages.


Organ Transplant Recipients Are at Increased Risk for a Range of Cancers

Organ transplant surgeryPatients who have received a solid organ transplant, such as a kidney, lung, or heart transplant, are twice as likely to develop cancer as the general population, and the risk extends to a broad range of cancers, according to research published November 1 in JAMA.

Doctors have known since the early days of organ transplantation that cancer is a possible complication of this often life-saving procedure. The new study gives researchers the first overview of cancer risk patterns in a large population of solid organ transplant recipients in the United States, including risk patterns for less common cancers. Read more > >



  • CDC Update

    • Committee Recommends Routine HPV Vaccination for Boys
    • CDC Launches Initiative to Prevent Infections among Cancer Patients
  • Update

    • Recovery Act Funds Advances in Breast Cancer Detection, Treatment, and Prevention
    • Online Education and Training for Health Professionals Now Easily Accessible
  • Notes

    • NCI Recognizes 11 Clinical Investigators with Leadership Awards
    • NCI Program Pairs Young Public Health Professionals with Mentors
    • TCGA to Hold First Annual Scientific Symposium
    • SEER Releases New U.S. Cancer Mortality Data, Cancer Statistics Review 2011

Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at

Next Section >